You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 5,846,519


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,846,519
Title: Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
Abstract:A method for imaging mammalian tissue utilizing a non-ionic complex of a paramagnetic ion of lanthanide element and a macrocyclic chelating agent.
Inventor(s): Tweedle; Michael F. (Princeton, NJ), Gaughan; Glen T. (Oxford, GB2), Hagan; James J. (Holmdel, NJ)
Assignee: Bracco Diagnostics Inc. (Princeton, NJ)
Application Number:08/471,591
Patent Claim Types:
see list of patent claims
Formulation; Compound;
Patent landscape, scope, and claims:

United States Patent 5,846,519: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 5,846,519, titled "Method for imaging mammalian tissue using a non-ionic complex of a paramagnetic ion of a lanthanide element and a macrocyclic chelating agent," is a significant patent in the field of medical imaging. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Invention Description

The patent describes a method for imaging mammalian tissue using a non-ionic complex of a paramagnetic ion of a lanthanide element and a macrocyclic chelating agent. This method is particularly useful in magnetic resonance imaging (MRI) to enhance the contrast and visibility of specific tissues or structures within the body[5].

Technical Background

The invention leverages the properties of lanthanide ions, which are known for their strong magnetic moments, making them effective as MRI contrast agents. The use of a macrocyclic chelating agent ensures the stability and safety of the complex, preventing the release of toxic lanthanide ions in the body.

Scope of the Patent

Claim Scope

The patent includes several claims that define the scope of the invention. These claims are crucial as they determine the extent of protection granted to the patentee. Here are some key aspects of the claim scope:

  • Independent Claims: The patent includes independent claims that broadly describe the method of imaging mammalian tissue using the specified complex. These claims are essential as they set the boundaries of what is considered novel and non-obvious[5].
  • Dependent Claims: Dependent claims further narrow down the scope by adding specific limitations or details to the independent claims. These claims help in ensuring that the patent is not overly broad and is anchored to the specific embodiments disclosed in the specification[3].

Claim Construction

The claims must be particularly pointed out and distinctly claimed, as required by 35 U.S.C. ยง 112. This means that the claims should inform those skilled in the art about the scope of the invention with reasonable certainty. Any ambiguity or indefiniteness in the claim language can lead to invalidation of the patent[2].

Claims Analysis

Key Claim Elements

  • Paramagnetic Ion: The claims specify the use of a paramagnetic ion of a lanthanide element, which is a critical component of the contrast agent.
  • Macrocyclic Chelating Agent: The use of a macrocyclic chelating agent is essential for stabilizing the lanthanide ion.
  • Imaging Method: The method involves administering the complex to a mammalian subject and then performing MRI to visualize the targeted tissue.

Claim Validity

The validity of the claims can be challenged on several grounds, such as prior art, written description, and enablement. For instance, if the claims are too broad and do not have sufficient support in the specification, they may be invalidated for failing to meet the written description requirement[3].

Patent Landscape

Prior Art and Novelty

The patent landscape in the field of MRI contrast agents is highly competitive. To secure a patent, the invention must be novel and non-obvious over the existing prior art. The USPTO conducts thorough searches to ensure that the claimed invention is not anticipated by prior art[1].

Global Trends in Medical Imaging Patents

Medical imaging, including MRI technologies, is a rapidly evolving field with significant global patent activity. According to the USPTO, patents in the electrical engineering and medical technology areas have seen substantial growth, reflecting the increasing importance of advanced imaging techniques[4].

Competing Patents and Litigation

In the medical imaging sector, patent litigation is common due to the high stakes involved. Patents like US 5,846,519 must navigate through a complex landscape of competing patents and potential infringement claims. For example, disputes over claim scope and validity, as seen in cases like Maxell, Ltd. v. Amperex Technology Limited, highlight the importance of precise claim drafting and robust patent strategies[2].

Practical Implications

Commercial Use and Licensing

The commercial use of the patented method involves licensing agreements and potential collaborations with pharmaceutical and medical device companies. The scope of the claims directly impacts the licensing terms and the ability to enforce the patent against infringers.

Research and Development

For researchers and developers in the field, understanding the scope of this patent is crucial to avoid infringement. It also provides a foundation for further innovation, as new methods and improvements can be developed around the existing patented technology.

Regulatory and Legal Considerations

USPTO Guidelines

The USPTO provides various tools and resources for patent searching and analysis, such as the Patent Public Search tool and the Global Dossier service. These resources are essential for navigating the patent landscape and ensuring compliance with USPTO guidelines[1].

Court Decisions and Precedents

Court decisions, such as those related to the abstract idea exception and claim indefiniteness, set important precedents for patent validity and enforcement. Understanding these legal frameworks is vital for maintaining the integrity and enforceability of the patent[2][3].

Key Takeaways

  • Precise Claim Scope: The scope of the claims in US Patent 5,846,519 is critical for defining the invention and ensuring enforceability.
  • Novelty and Non-Obviousness: The patent must be novel and non-obvious over prior art to be valid.
  • Regulatory Compliance: Adherence to USPTO guidelines and awareness of legal precedents are essential for maintaining patent validity.
  • Commercial and Research Implications: The patent's scope affects licensing, commercial use, and further research and development in the field.

FAQs

What is the main invention described in US Patent 5,846,519?

The main invention is a method for imaging mammalian tissue using a non-ionic complex of a paramagnetic ion of a lanthanide element and a macrocyclic chelating agent.

Why is the claim scope important in a patent?

The claim scope is crucial as it defines the boundaries of what is protected by the patent. It must be precise and anchored to the embodiments disclosed in the specification to avoid invalidation.

How does the USPTO ensure the novelty of a patent?

The USPTO conducts thorough searches of prior art to ensure that the claimed invention is novel and non-obvious.

What are the potential risks of having overly broad claims in a patent?

Overly broad claims can lead to invalidation due to failure to meet the written description requirement or the abstract idea exception.

How does patent litigation impact the medical imaging sector?

Patent litigation in the medical imaging sector can significantly impact the development and commercialization of new technologies, highlighting the need for robust patent strategies and precise claim drafting.

Sources

  1. USPTO: Search for patents - USPTO. (2018, October 18).
  2. CAFC: MAXELL, LTD. v. AMPEREX TECHNOLOGY LIMITED. (2024, March 6).
  3. Rimon Law: The Importance of Getting the Claim Scope Right in a US Patent Application. (2021, October 4).
  4. NCSES: Invention: U.S. and Comparative Global Trends. (2020, January 15).
  5. Justia Patents: US Patent for Method for imaging mammalian tissue using 1.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,846,519

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.